New Zealand
CDH exits New Zealand supplements brand to Nestle
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.
Fund focus: LPs endorse Potentia’s software thesis
Potentia Capital took just four months to close its second fund on USD 438m, emphasizing the growing appeal of B2B technology opportunities in Australia and New Zealand
New Zealand deep-tech VC Pacific Channel seeks co-investors
Pacific Channel, which claims to be the largest deep-tech specialist in New Zealand’s venture capital industry, is seeking co-investors to support maturing portfolio companies that require additional capital.
Navis backs Australasia software aggregation platform
Navis Capital Partners has invested in Software Combined, an Australia and New Zealand-based aggregator of software providers that cater to specific niches or B2B verticals.
New Zealand's GD1 backs tech fund, incubator
GD1 has confirmed it is the lead investor in a new fund and incubation program from fellow New Zealand VC firm Phase One Ventures. The goal is to produce 10 tech unicorns by 2026.
New Zealand's Pushpay confirms PE approaches
Pushpay, a New Zealand and Australia-listed payments business specialising in donor management, confirmed it had been approached by prospective buyers but played down the significance of an agreement with BGH Capital and Sixth Street Partners.
Deal focus: ICG finds alignment with doctor-shareholders
Intermediate Capital Group believes its flexible approach to deal structuring – and a willingness to share upside – helped win over doctors who are employees and part-owners of Canopy Healthcare
Vodafone New Zealand buys out PE partner in retail JV
Millennium Corp, a specialist technology, media, and telecom (TMT) investor operating in New Zealand and the Pacific region, has exited its 50% stake in Vodafone New Zealand’s retail stores.
ICG buys New Zealand's Canopy Healthcare
ICG has acquired Canopy Healthcare Group, a New Zealand-based healthcare platform that offers diagnostic imaging, medical oncology, and drug compounding services.
GD1 launches New Zealand's first crypto VC fund
New Zealand’s GD1 has launched what it calls the first dedicated crypto and Web3 VC fund in its home market less than a week after a similar claim by PAC Capital in Australia.
Australia's Mercury targets $595m for Fund IV
Australian mid-market private equity firm Mercury Capital is targeting AUD 800m (USD 595m) for its fourth fund.
CPE sells New Zealand shipping business to Morgan Stanley
Australian middle-market private equity firm CPE Capital has sold StraitNZ, a ferry and logistics operator that runs services across the Cook Strait between New Zealand’s North and South Islands, to Morgan Stanley Infrastructure Partners (MSIP).
Tiger Global leads Series A for New Zealand's ArchiPro
Tiger Global Management has led a NZD 35m (USD 24m) Series A round for New Zealand’s ArchiPro, a platform that connects homeowners with interior design and construction professionals.
Australia's BGH closes Fund II on $2.6b
BGH Capital has closed its second fund on approximately AUD 3.6bn (USD 2.6bn) after fewer than six months in the market. It represents the largest-ever private equity vehicle raised for deployment in Australia and New Zealand.
Infrastructure: Out of the comfort zone
Infrastructure managers in Australia are pushing into the PE space, competing with GPs for assets and buying businesses from them. It falls under the core-plus umbrella, but is the definition being stretched too far?
Silver Lake wins approval for New Zealand rugby deal
Silver Lake has won approval for a NZD 200m (USD 134m) investment in the commercial arm of New Zealand rugby, reflecting a recent upswing in global private equity involvement in sport in Asia.
New Zealand's Soul Machines raises $70m
SoftBank Vision Fund 2 has led a USD 70m round for New Zealand-based Soul Machines, which specialises in creating lifelike digital employees for customer engagement.
New Zealand's AskNicely raises $32m Series B
Five Elms Capital, a specialist growth investor in software start-ups globally, has led a USD 32m Series B round for New Zealand and US-based customer feedback platform AskNicely.
PE consortium backs New Zealand fertility business
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
PEP sells Australia, New Zealand healthcare businesses
Pacific Equity Partners (PEP) has agreed two healthcare exits, with Australia-based medical devices distributor LifeHealthcare to be sold to Ebos Group and New Zealand corporate hospital platform Evolution Healthcare going to QIC and Sunsuper.
Australia's Five V raises $398m for Fund IV
Five V Capital, a growth-oriented investor in Australia and New Zealand, has achieved a first and final close on its fourth fund with more than A$550 million ($398 million) in commitments.
Australia's Rampersand targets $29m for fourth VC fund
Rampersand, an Australia-based VC investor, is looking to raise A$40 million ($29.6 million) for its fourth fund, which will address what the firm describes as a “chronic funding gap in early-stage seed funding.”